NOTE 14 – INCOME TAXES

The following table summarizes income before income taxes for the year ended December 31, 2025:

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

Domestic

$

(43,229,170

)

 

$

14,214,024

 

Foreign

 

143,985

 

 

 

1,443,910

 

Total

$

(43,085,185

)

 

$

15,657,934

 

The Company’s effective tax rate for each year ended December 31, 2025 and 2024 was 0.00%.

The following is a reconciliation from the Company’s statutory rate to the effective tax rate reported in the financial statements for the year ended December 31, 2025:

For the Year Ended December 31,

 

 

2025

 

Income tax at the U.S. federal statutory rate

$

(9,047,889

)

 

 

21.00

%

Foreign tax effects:

 

 

 

 

 

Mexico

 

 

 

 

 

Statutory tax rate difference between Mexico and U.S.

 

(568,789

)

 

 

1.32

%

Change in valuation allowance

 

1,895,962

 

 

 

-4.41

%

Panama

 

 

 

 

 

Statutory tax rate difference between Panama and U.S.

 

(1,559,295

)

 

 

3.62

%

Other foreign jurisdictions

 

201,885

 

 

 

-0.47

%

Effect of cross-border tax laws:

 

 

 

 

 

Other

 

88,063

 

 

 

-0.20

%

Tax credits:

 

 

 

 

 

Other

 

34,855

 

 

 

-0.08

%

Change in valuation allowance

 

2,607,836

 

 

 

-6.05

%

Non-deductible or non-taxable items:

 

 

 

 

 

Change in fair value of derivative liabilities

 

5,924,865

 

 

 

-13.75

%

Note payable interest accretion

 

323,742

 

 

 

-0.75

%

Other

 

2,058

 

 

 

0.00

%

Other adjustments

 

96,707

 

 

 

-0.23

%

Total income tax provision

$

 

 

 

0.00

%

For the year ended December 31, 2025, the primary drivers of the variance from the statutory rate were changes in the fair value of derivative liabilities, the foreign rate differential, changes in the domestic and foreign valuation allowances, and state income taxes. The Company’s state income taxes relate primarily to the State of Florida.

The following is a reconciliation from the Company’s statutory rate to the effective tax rate reported in the financial statements for the year ended December 31, 2024:

 

For the Year Ended

 

 

December 31, 2024

 

Income tax at the U.S. federal statutory rate

$

3,093,385

 

Effects of:

 

 

State income taxes, net of federal benefits

 

640,036

 

Nondeductible expense

 

589,781

 

Subpart F income

 

1,305,118

 

Derivatives fair value

 

(3,357,883

)

Change in valuation allowance

 

2,369,354

 

OML termination

 

1,076,377

 

Foreign rate differential

 

(5,716,168

)

Total income tax provision

$

 

 

For the year ended December 31, 2024, the primary drivers of the variance from the statutory rate were related to changes in the fair value of derivative liabilities, SubPart F income, the foreign rate differential, changes in the domestic and foreign valuation allowances, and state income taxes. The Company’s state income taxes relate primarily to the State of Florida.

The tax effect of temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases that give rise to deferred tax assets and liabilities is as follows:

For the Year Ended December 31,

 

 

2025

 

 

2024

 

Deferred tax assets

 

 

 

 

 

Net operating loss and tax credit carryforwards

$

56,737,895

 

 

$

53,001,831

 

Stock option and restricted stock award expense

 

2,351,238

 

 

 

2,294,947

 

Debt Extinguishment

 

 

 

 

61,945

 

Gross deferred tax assets

 

59,089,133

 

 

 

55,358,723

 

Valuation allowance

 

(58,855,400

)

 

 

(55,169,826

)

Net deferred tax assets

$

233,733

 

 

$

188,897

 

Deferred tax liabilities

 

 

 

 

 

Property and equipment basis

 

(65,660

)

 

 

(40,393

)

Prepaid expenses

 

(168,073

)

 

 

(148,504

)

Total deferred tax liabilities

 

(233,733

)

 

 

(188,897

)

Total deferred tax assets (liabilities)

$

 

 

$

 

For the year ended December 31, 2025, the Company had federal, state post-apportioned, and foreign net operating loss carryforwards of $212.1 million, $79.6 million and $29.1 million, respectively. Of the federal amount, $154.4 million has a limited carryforward period and will begin to expire in 2026; the remaining $57.7 million will have an indefinite carryforward period. Of the state post-apportioned amount, $35.5 million has a limited carryforward period and will begin to expire in 2028; the remaining $44.0 million will have an indefinite carryforward period. Of the foreign amount, $29.1 million has a limited carryforward period and will begin to expire in 2026.

For the year ended December 31, 2025, the Company has federal tax credit carryforwards of $34,855. The company does not have any state or foreign related tax credit carryforwards. Of the federal amount, $34,855 has a limited carryforward period and will begin to expire in 2031.

In accordance with Section 382 and Section 383 of the IRC, utilization of the net operating loss and tax credit carryforwards may be subject to limitations based on prior or future ownership changes. The Company has determined that the cumulative shifts in ownership of its common stock from 2022 to 2025 have resulted in a limitation on its use of the net operating loss and tax credit carryforwards. The Company is currently evaluating the amount of the limitation in accordance with Section 382 and Section 383.

In assessing the realizability of deferred tax assets under ASC 740, management evaluated all available positive and negative evidence, with greater weight placed on evidence that is objectively verifiable. The negative evidence management considered included the Company’s history of cumulative losses in recent years, current‑year operating losses, and forecasted future losses, as well as the magnitude of net operating loss and other tax credit carryforwards relative to projected taxable income. Management also considered the limited ability to carry back losses, the timing of reversals of deferred tax assets, and the impact of applicable utilization limitations. Positive evidence evaluated included the nature and timing of future taxable income projections, the existence of taxable temporary differences, and the availability of feasible tax planning strategies. After weighing this evidence, management concluded that the negative evidence outweighed the positive evidence and that it is more likely than not that the Company’s deferred tax assets will not be realized without the recovery and rights of ownership or salvage rights of high-value shipwrecks or other forms of taxable income. Accordingly, a valuation allowance of $58.9 million was recorded against the deferred tax assets as of December 31, 2025.

For the year ended December 31, 2025, the Company considers all foreign earnings to be permanently reinvested.

The Company is subject to income tax in multiple jurisdictions, including federal, state, and foreign jurisdictions. The Company has federal, state, and foreign income tax returns open to examination for 2022 to 2024, 2022 to 2024, and 2020 to 2024 forward, respectively. In addition, the utilization of tax carryforwards, from periods prior to those previously mentioned may also be audited by the taxing authorities once utilized. As a result, the Company continuously monitors its current and prior filing positions in order to determine if any unrecognized tax positions need to be recorded. The Company recognizes the effect of income tax positions only if

those positions are more likely than not to be sustained upon examination. Based on management’s evaluation as of December 31, 2025, the Company has determined that no such positions exist and, therefore, no unrecognized tax benefits have been recorded under ASC 740.

For the year ended December 31, 2025, the Company did not make any income tax payments to federal, state, or foreign taxing authorities. The Company’s operating results for the year, together with management’s current projections, indicate taxable losses, resulting in no income taxes payable or paid during the year.

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Mar 31, 2025
2023May 17, 2024

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.